Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study
Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.
Peptide Chemistry
FDA Gives Green Light to Long-Awaited Botox Competitor
Competition between cosmetic treatments begins.
Drug Discovery & Development
Immuno Oncology Investigations: The NKG2D Pathway, Diagnostic Biomarker, and Allogenic CAR Ts
Cell UK 2021 hosts experts in cell and immunotherapy working towards new diagnostic tools and therapies.
In Conversation With Pedro Caetano Pinto, Lab Lead in Experimental Urology, Universität Greifswald
We interview Pedro-Caetano Pinto, Lab Head at the University of Greifswald to learn more about his work with microphysiological systems for advanced kidney and prostate cancer research.
Drug Discovery & Development
Express Your Cells: Enhancing T Cell Function with Small Molecule HPK1 Inhibitors
Inhibiting the HPK1 pathway can enhance the cancer killing function of T lymphocytes. RAPT Therapeutics showcases a series of small molecules to do this.
NextGen Therapeutics
Retinal Disease Drug Receives Approval from European Commission
Ranivisio is a biosimilar of Lucentis which treats serious retinal diseases.
Q and A with Vasiliki E. Kalodimou
Vasiliki Kalodimou of the NCSR DEMOKRITOS, discusses her work in cell therapy analytics, ahead of Oxford Global's Cell Therapy Analytics Event.
Using Humanised Mice to Evaluate Vaccine Efficacy
Kymab Ltd presents the utility of mice models for studying human immune response to complex vaccines.
Stem Cell Therapy
Combinatorial Culture Technology for Stem Cell Therapy Applications
How can combinatorial screening of diverse variables in process development optimise cell and gene therapies? Marina Tarunina, Research Director at Plasticell, investigates.
Drug Discovery & Development
iNKT Cells and Their Applications in Immuno-Oncology
The applications of iNKT cells as oncological therapeutics and remedial treatments are almost astoundingly diverse. Their capacity for moderation subject to their intended use makes them suited to a variety of therapeutic functions and applications.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery